9999999997-11-009722.txt : 20110503 9999999997-11-009722.hdr.sgml : 20110503 20110503135907 ACCESSION NUMBER: 9999999997-11-009722 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20110503 DATE AS OF CHANGE: 20110503 20110503 20110503 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-23143 FILM NUMBER: 11804381 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$P(#`@;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S M=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@("`@#0HR M,B`P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22`X-"],(#8X+TQE;F=T M:"`V,2]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G``(.)094P`C$+`P<#7!E+T-A=&%L;V<^/@UE;F1O8FH-,3(@ M,"!O8FH-/#PO0V]N=&5N=',@,30@,"!2+T-R;W!";WA;,"`P(#8Q,B`W.3)= M+TUE9&EA0F]X6S`@,"`V,3(@-SDR72]087)E;G0@."`P(%(O4F5S;W5R8V5S M(#$V(#`@4B]2;W1A=&4@,"]4>7!E+U!A9V4^/@UE;F1O8FH-,3,@,"!O8FH- M/#PO1FEL=&5R+T9L871E1&5C;V1E+T9I/0I MT[D7=;5.M%FRQ=V4I?I@5J,1AO]8P"^5-QH/,Q`L&;>?R0SX%RY9^K;7IYJL MVCN_S1TW:UT:B(>"W:K]5YUM=P9U87\<&^J4.5GZYNK0C/K08>U+Y+!I,HW ML]3Z$U-KL]ZQ>547*K>F)RC[+@[M%..R@B"T7GA^?\$GMCK7KQ/H.6NI8C8HM=V)+DJ[AQ;&COJ')7N=$[=:1!#5+F_6YY: M77W^B.QSW;93K"M[/JN`=R3^$6``0IF)4PT*96YDO&*`O5&%Q=9"6O6]>'UEW&V<1*T"!I"ADF;99 M*))71[/Y]QU>OI*-@Y@C<3C'-]\,_>EF%<*NZ7U)>Y_2-((0TFTOC"#`/UQ& M`23!D`X9I,^]`';XG^;JZZ5'P$O_[85#\$,:M\-)[)`_+13KS?$9'9`HKS^W^D?/7]`DX1?V@P& MUJ82E,W5;/)POT@7'FHS-`#CY13024P'Y*_)U_'RQC[`Y.[V=K%:+>Z6UGQ" MH_C,_)MD.66G7>4R5!J^E5#M-GN%N`]1$(;Z1$0'OS;GAQ$-V%4V#J'`(G1W M/YW=PXWG#Q&5^_$R72QO,/#E7$>,%AC#4KG3D3W-(W-Z,9WAB?&?D-[/QNDM M/MA,\>"`\\MD(E<3Y3'].@.')&(XL\C!>)+"W1S"4:P*$Q%F#6*1V$?0X<;@ MRA\_@L>-Y^]UM1.ES!OX[@UH3/9>B*7/ZNMTE'9@N='"0^0B.=Y)Y@U':JDO2%NV55NY4:4KKBEL0=9N M2!CXWV"+-=\`.KS-ZGP/(3<-2MVXNN:,1>5HRX5L"T:^9(VQ5XM#+1K$)E-H M>ZH=&EB_PED]]UFMHXT"RJ,S.$;..+-32Z66D$NBH\41P7*W^ZS%+]F<@$Z( M]FFAL-8OH&!'#YIOY$>7%7(K10-93Q9*V MS$JMJ`-1$W:@(X]L.%VIN*9*.*^%V%1F#ZJMJYDQ>PP4)Y3+*+0FQGG;!PX/ M=$4G%#B/GLCZR7LB[,GK:\M3^=^18@[24PD?2:.LH,=)51^JVAB=2Q6X@#WF MOA&M0(\)$DJ66,@CFZ*KF\6,]+)J%0T/W1I[JWB%C6SRHFH$TI>"F1@!'0Y. MI;VZ$Q[).,^K>H/-5+SV3XRWI4RPQ)F;Y3Q\KV.4I.SH3"X;95L51?6B^E28 MEG&$B&E\?5&&EL8OLBA`965FB&ID1I#+A<@:CQ,,#=-M]V;3YJV[7#ELI?%N M3QU$+:L--`>1*VYM]*'/Q^%RW5EF)+++ZQ-G)QO9VP[`]3YXNM<0VSA!F3&N M,JZK;K>W6W=Y6ZV1;5:Q;X4HB`(30/#K:\&V^)M2N1:?VW0GV!JZ1+)1M.JK M[G8QQL]*H89W'DY8G7EI%HD+4RV2*0%_`1(+[XU:(M3O MS//!+.VY/H]/^E^T_LE,K06W6*>-6IB:%(XY;\*S?H2SDSOA;:2%>V-#F)@0 MK"\=-W=Y*L]LA/;%^6E,4)UF24`NN7R%YRSM_2_``(#ZR5$-"F5N9'-T,E,P4#!7 M,+10L+'1]RO-+8X&<0T4@F+M[(`BP?HN=G8``08`C84(-PT*96YDFMC.60B/SX*/'@Z>&UP;65T82!X;6QN M#IX;7!T:STB061O8F4@6$U0($-O&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT"UD969A=6QT M(CY-:6-R;W-O9G0@5V]R9"`M('!R;V=E;FEC&UP34TZ M26YS=&%N8V5)1#YU=6ED.CEF9#EE,S)E+3$S.&4M-#%A82UA,C(V+38X,#-A M,C-A-&)C-CPO>&UP34TZ26YS=&%N8V5)1#X*("`@("`@/"]R9&8Z1&5S8W)I M<'1I;VX^"B`@(#POJ'5!:DZ@'`F+AG?=5X`!`'L91,`-"F5N9'-T MF4@,3`O5'EP92]84F5F+U=;,2`R(#%=/CYS=')E86T-"FC> M8F(``B9&KD,,3`R,;4""+QW$Z@41_$")I]N`+`8&1B#!]!](,#(`!!@`>.P% K&PT*96YD